|
|
name  click to compare prices |
| 4-WayNasal | | Ability, Alpha Keri, Ammens | Ban, Bristol Myers  , Bristol Myers Squibb, Bufferin, BuSpar | | Cardiolite, Comtrex, Coumadin | | DuPont Pharmaceutical | | Elisor, Excedrin | | Fisherman’s Friend, Fostex | | Glucophage | | Herbal Essences | | Keri, Kosan Biosciences | | Medarex, Moisturel | | NoDoz, Nuprin | | Platinol, PreSun | | Saugella, Sea Breeze, Squibb, Sustiva | | Taxol, Tempra, Therapeutic Mineral Ice | | Vagistat-1 |
» Shop local, ethical and at the best price on Ethishop  |
|
| |
|
| shareholder | country | % | source |
|
year | business source |
| 2006 | Bristol Myers Squibb is the world's thirteenth-largest pharmaceutical group. | Les Echos |
|
| country | address & contact : production type incentive source |
 Bermuda | Bristol-Myers Squibb Service Ltd : |
| Bermuda | Grove Insurance Company Ltd : |
 Brazil | : Centro Nuovo Modello di Sviluppo |
 Colombia | : Centro Nuovo Modello di Sviluppo |
 Costa Rica | Bristol-Myers Squibb de Costa Rica, S.A : |
 Dominica | Bristol-Myers Industrial inc. : |
 Guam | Bristol-Myers Overseas Corporation : |
 Iran | : Centro Nuovo Modello di Sviluppo |
 Ireland | Bristol-Myers Squibb Pharmaceuticals Ltd : |
 Lebanon | Bristol-Myers Middle East S.A.L : |
 Mexico | DISTRITO FEDERAL ALVARO OBREGON REVOLUCION 1267 TLACOPAC & 5 2274800 : Sistema de Informacion de la Industria Maquiladora |
| Mexico | DISTRITO FEDERAL AZCAPOTZALCO PONIENTE 150 764 INDUSTRIAL VALLEJO & 7295400 : Sistema de Informacion de la Industria Maquiladora |
 Pakistan | Bristol-Myers Pakistan (Pvt.) : |
 Panama | Squibb Middle East S.A : |
| Panama | Bristol Pharmaceutical Information Center, S.A : |
| Panama | Bristol Laboratories Products, Inc. : |
 Peru | : Centro Nuovo Modello di Sviluppo |
 Singapore | Bristol-Myers Squibb (Singapore) Pte. Ltd : |
 Turkey | : Centro Nuovo Modello di Sviluppo |
|
| year name | photo position; compensation source |
| 2002Dolan, Peter |  Chief Executive Officer; salary: 1,15 million US$; L'Expansion |
| 2000Dolan, Peter | Chief Executive Officer; salary: 6,7 million US$;
|
| 1998Heimbold, Charles | Chief Executive Officer; salary: 3,19 million US$; stock-options: 30,37 million US$;
|
|
| year | employees <> | social impact : country source |
| 2009 | -123 | Closure/Bankruptcy: BMS closes its Epernon facility because of drug manufacturing overcapacities.: France | Les Echos |
| 2009 | -160 | Closure/Bankruptcy: Bristol Myers Squibb closes its factory of Meymac in Corrèze.: France | Capital |
| 2007 | -4300 | Internal restructuring: Bristol Myers Squibb cuts 10% of its global workforce.: | Reuters |
| 2007 | -4300 | Closure/Bankruptcy: Bristol Myers Squibb will cut its work force by 10 percent by 2010 and slash the number of its manufacturing plants by more than half, to generate an additional $1.5 billion in savings. Bristol Myers Squibb raised its 2008 earnings per share forecast, excluding special items, to $1.65 to $1.75 from a previous view of $1.60 to $1.70. That translates into an expectation of earnings growth next year of up to 19 percent.: | Reuters |
| 2005 | -41 | Closure/Bankruptcy: Mise en vente de son centre de recherche et développement de Saint-Nazaire dans le cadre d'un regroupement de sa recherche. Si aucun repreneur ne se manifeste, cette unité sera fermée.: | Les Echos |
|
| year | employees <> | social impact : country source |
|
| year | country : consequences source |
| 2005 | brand: Ability : Older patients with dementia who are given antipsychotic medicines are far more likely to die prematurely than those given placebos. Most died of heart-related problems like heart failure or infections like pneumonia (FDA) | New York Times |
|
| year | country : consequences source |
|
| year | financial misdemeanor | sales | income | | buyback | source |
| 2007 |
| 19,3 | 2,2 | | | billion US$ | Les Echos |
| 2005 |
Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said. |
| | | | | | Bloomberg |
| 2005 |
Agreed to pay $300 million in a deal to defer federal prosecution of a conspiracy charge stemming from an accounting scandal. Frederick Schiff, Bristol-Myers former chief financial officer, and Richard Lane, former executive vice president and president of the worldwide medicines group, were indicted on charges of conspiracy and securities fraud. |
| | | | | | AP |
| 2005 |
Has paid about $155,000 to New Mexico as the state's share in the settlement of an antitrust lawsuit; aaccused of overcharging health care services for the cancer-fighting drug Taxol and Children's Motrin |
| | | | | | AP |
| 2004 |
| | 2,4 | | | billion US$ | Les Echos |
| 2004 |
Overstated profits from 1999 to 2002 by 700 millions US$ |
| | | | | | Chicago Tribune |
| 2004 |
Agreed to pay $150 million to settle U.S. Securities and Exchange Commission allegations that it inflated sales by misusing discounts and incentives to drug wholesalers. |
| | | | | | Bloomberg |
| 2003 |
| 20,67 | 2,95 | | | billion US$ | Les Echos |
| 2003 |
Will pay about $670 million to settle allegations that it unlawfully delayed competition for its BuSpar anti-anxiety medication and Taxol cancer therapy. |
| | | | | | Bloomberg |
| 2002 |
| 18,12 | 2,07 | | | billion US$ | |
| 2002 |
SEC probe of sales practices: by offering incentives to wholesalers, BMS may have boosted revenue by as much as $1 billion. |
| | | | | | CNN |
| 2001 |
| 19,42 | 5,25 | | | billion US$ | |
| 2000 |
| 18,22 | 4,71 | | | billion US$ | |
| 1999 |
| 20,22 | 4,17 | | | billion US$ | |
| 1999 |
| | | | 2 | billion US$ | SmartMoney |
| 1998 |
| 18,28 | 3,14 | | | billion US$ | |
|
| year | financial misdemeanor | sales | income | assets | buyback | source |
|
| year | purpose : intermediary/lobby : institution source |
| 2001 | Access to foreign market (through MAI, WTO, GATS), prevent binding environmental regulations : USCIB (US Council For International Business) : : US Government  translate | USCIB |
| 2000 | Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translate | Washington Post |
| 2000 | Investment protection and market access (to Mexico and Canada through NAFTA), to Latin America (through FTAA). : Business Roundtable : : US government, senate, congress translate | Center for Responsive Politics |
| 2000 | Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translate | EFPIA |
| 2000 | Prevent binding regulation, co- or self-regulation instead. : American Chamber of Commerce's EU Committee : : European Commission translate | Corporate Europe Observatory |
| 1999 | Protection of Intellectual Property -TRIPS Agreement : Intellectual Property Committee : : WTO translate | Corporate Europe Observatory |
| 1999 | Market access and investment protection (through WTO, GATS), avoid social and environmental rules : ICC (International Chamber of Commerce) : : WTO, GATS translate | Corporate Europe Observatory |
| 1998 | Regulation favorable to company's interests : Contribution to Candidate's Political Action Committee : amount: 212 thousand US$ : US President, Congress, Senate translate | Center for Responsive Politics |
| 1997 | Legislation favorable to company's interests : Direct donation : amount: 3780 thousand US$ : US President, Congress, Senate translate | Center for Responsive Politics |
| 1997 | Legislation favorable to company's interests : Direct donation : amount: 631 thousand US$ : US President, Congress, Senate translate | Center for Responsive Politics |
|
| year | purpose : intermediary/lobby : institution source |
|
| year | donator | country | amount | source |
| 1998 | Etat | France | 1 million Eu€ | Les Echos |
|
| year | donator | country | amount | source |
|
| year | dubious practice : image source |
| 2004 | Arguable partnership: Don pour les victimes du tsunami: 1000000 de dollars: value: Humanitaire; | AFP |
| 2001 | ad budget: 485 million US$; | Advertising Age |
| 2000 | Disinformation: PR campaign with Ketchum PR: public relations: K | PR Watch |
| 2000 | ad budget: 424 million US$; | Advertising Age |
|
|
|
&sa=OK&client=pub-2642534665785160&forid=1&channel=6290198667&ie=ISO-8859-1&oe=ISO-8859-1&flav=0002&sig=NuXwWEvBGZspbgPc&cof=GALT%3A%23CEA7FF%3BGL%3A1%3BDIV%3A%234A4A4A%3BVLC%3AFF6600%3BAH%3Acenter%3BBGC%3A4A4A4A%3BLBGC%3A4A4A4A%3BALC%3AFFB42D%3BLC%3AFFB42D%3BT%3AFFFFFF%3BGFNT%3AE8DBEF%3BGIMP%3ACEA7FF%3BLH%3A26%3BLW%3A304%3BL%3Ahttp%3A%2F%2Fwww.transnationale.org%2Fimages%2Ftrans2.gif%3BS%3Ahttp%3A%2F%2Fwww.transnationale.org%3BFORID%3A11&hl=en){kind=link}
&sa=OK&client=pub-2642534665785160&forid=1&channel=6290198667&ie=ISO-8859-1&oe=ISO-8859-1&flav=0002&sig=NuXwWEvBGZspbgPc&cof=GALT%3A%23CEA7FF%3BGL%3A1%3BDIV%3A%234A4A4A%3BVLC%3AFF6600%3BAH%3Acenter%3BBGC%3A4A4A4A%3BLBGC%3A4A4A4A%3BALC%3AFFB42D%3BLC%3AFFB42D%3BT%3AFFFFFF%3BGFNT%3AE8DBEF%3BGIMP%3ACEA7FF%3BLH%3A26%3BLW%3A304%3BL%3Ahttp%3A%2F%2Fwww.transnationale.org%2Fimages%2Ftrans2.gif%3BS%3Ahttp%3A%2F%2Fwww.transnationale.org%3BFORID%3A11&hl=en){kind=link}
